Business Description
Nova Pharma Solutions Bhd
ISIN : MYL03006O003
Compare
Compare
Traded in other countries / regions
03006.Malaysia IPO Date
2018-03-09Description
Nova Pharma Solutions Bhd provides engineering solutions to pharma and biotech industries. The company's reportable segments include Design fee, Post Design, & Other support fees. Design fee comprises conceptual designs which include user requirement specification, capacity analysis and process scheduling with detailed costing, list of deliverables, details specification of various equipment and processes. Post design fee comprise tendering and procurement support as well as the construction of a plant, & Other support fees comprise of services to assist a customer in the good manufacturing practice document review & gap analysis and assessment. It generates a majority of its revenue from the Design fee segment. Geographically, the company generates a majority of its revenue from Malaysia.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 91.26 | |||||
| Equity-to-Asset | 0.79 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.04 | |||||
| Interest Coverage | 167.81 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 9.69 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.3 | |||||
| 3-Year EBITDA Growth Rate | 6.9 | |||||
| 3-Year EPS without NRI Growth Rate | -5 | |||||
| 3-Year Book Growth Rate | 1.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.78 | |||||
| Quick Ratio | 4.78 | |||||
| Cash Ratio | 3.34 | |||||
| Days Sales Outstanding | 90.34 | |||||
| Days Payable | 22.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Payout Ratio | 0.19 | |||||
| 3-Year Dividend Growth Rate | -9.1 | |||||
| Shareholder Yield % | -0.29 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 58.11 | |||||
| Operating Margin % | 29.97 | |||||
| Net Margin % | 26.6 | |||||
| FCF Margin % | 38.29 | |||||
| ROE % | 20.04 | |||||
| ROA % | 16.25 | |||||
| ROIC % | 55.59 | |||||
| ROC (Joel Greenblatt) % | 253.33 | |||||
| ROCE % | 25.58 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 14.38 | |||||
| PE Ratio without NRI | 14.38 | |||||
| Price-to-Owner-Earnings | 76.67 | |||||
| PS Ratio | 3.83 | |||||
| PB Ratio | 2.58 | |||||
| Price-to-Tangible-Book | 2.56 | |||||
| Price-to-Free-Cash-Flow | 10 | |||||
| Price-to-Operating-Cash-Flow | 10 | |||||
| EV-to-EBIT | 8.47 | |||||
| EV-to-EBITDA | 8.1 | |||||
| EV-to-Revenue | 2.9 | |||||
| EV-to-FCF | 7.57 | |||||
| Price-to-Projected-FCF | 2.09 | |||||
| Price-to-Graham-Number | 1.28 | |||||
| Price-to-Net-Current-Asset-Value | 2.56 | |||||
| Price-to-Net-Cash | 4.6 | |||||
| Earnings Yield (Greenblatt) % | 11.81 | |||||
| FCF Yield % | 10.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nova Pharma Solutions Bhd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil RM) | 8.959 | ||
| EPS (TTM) (RM) | 0.016 | ||
| Beta | -0.42 | ||
| Volatility % | 2.17 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (RM) | 0 | ||
| 20-Day SMA (RM) | 0.23 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (RM) | 0.23 - 0.23 | ||
| Shares Outstanding (Mil) | 149.01 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nova Pharma Solutions Bhd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nova Pharma Solutions Bhd Stock Events
| Event | Date | Price(RM) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nova Pharma Solutions Bhd Frequently Asked Questions
What is Nova Pharma Solutions Bhd(XKLS:03006)'s stock price today?
The current price of XKLS:03006 is RM0.23. The 52 week high of XKLS:03006 is RM0.23 and 52 week low is RM0.23.
When is next earnings date of Nova Pharma Solutions Bhd(XKLS:03006)?
The next earnings date of Nova Pharma Solutions Bhd(XKLS:03006) is .
Does Nova Pharma Solutions Bhd(XKLS:03006) pay dividends? If so, how much?
Nova Pharma Solutions Bhd(XKLS:03006) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers